Evidence map›Paper›PMID 41800451›Full record

ArticleFrontiers in oncology2025

Explainable and uncertainty-aware ensemble framework with causal analysis for breast cancer detection.

Muhammad Zaheer Sajid, Muhammad Fareed Hamid, Imran Qureshi

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammad Zaheer SajidDepartment of Electrical and Computer Engineering, George Mason University, Fairfax, VA, United States.
Muhammad Fareed HamidDepartment of Computer Software Engineering, Military College of Signals, National University of Sciences and Technology, Islamabad, Pakistan.
Imran QureshiCollege of Computer and Information Sciences, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is one of the main causes of cancer deaths around the world and is known for its aggressive growth and ability to spread. While machine learning has shown good results for diagnosis, most existing methods do not handle uncertainty or explain their predictions clearly. In this study, we present an integrated framework that combines uncertainty-aware ensemble learning with causal feature analysis and multimodal explainability for breast cancer prediction. The framework uses a mix of Light Gradient Boosting Machine (LightGBM), random forest, and gradient boosting classifiers that include uncertainty estimation so that the model can mark predictions that are less confident. It also applies causal analysis to detect possible clinical confounders and uses SHAP (Shapley Additive Explanations), permutation importance, and feature attribution for interpretation. Tests on two public datasets showed strong and consistent performance. On the UCTH Clinical Dataset, the model reached an area under the curve (AUC) of 0.97%, an accuracy of 0.95%, and an F1 score of 0.94%, with 100% precision for high confidence cases and no false positives. On the Breast Cancer Wisconsin dataset, it achieved an AUC of 0.99, an accuracy of 0.94%, and an F1 score of 0.92%, which increased to 0.98% accuracy and 0.98% F1 score when only certain predictions were considered. Causal analysis pointed out important clinical confounders like lymph node involvement, tumor size, and metastasis, while fairness tests showed balanced results across demographic groups. Overall, the framework combines uncertainty estimation and causal interpretability to give predictions that are both accurate and trustworthy. It provides clinicians with clear confidence levels for every prediction and supports transparent decision-making that can reduce diagnostic errors and improve reliability in clinical use.

Indexed as

breast cancer predictioncausal interpretabilityclinical decision supportensemble learningSHAP explainabilityuncertainty quantification

Identifiers

PMID41800451
PMCPMC12962921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.